LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (AMEX:SLP), a leading provider of software for pharmaceutical discovery and development, today announced that a top 5 pharmaceutical company has signed a five-year extension to a master services agreement with Simulations Plus.
